MANTA Ultrasound Closure Study — MANTA ULTRA

Femoral Arteriotomy Closure Clinical Trial

Official title:
Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study

Status Terminated

Clinical Trial Summary

Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.

Clinical Trial Description

The MANTA Vascular Closure Device is indicated for closure of femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures. This study is being conducted to demonstrate the safety of U/S guided closure with MANTA VCD following TAVR procedures utilizing large bore sheaths. ;

Study Design

Related Conditions & MeSH terms

Femoral Arteriotomy Closure

Clinical Trial Details

NCT number	NCT05142566
Study type	Interventional
Source	Essential Medical, Inc.
Contact
Status	Terminated
Phase	N/A
Start date	August 9, 2022
Completion date	January 11, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05936996` - Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
Not yet recruiting	`NCT06358157` - The Ladera Large Bore Closure Feasibility Study	N/A
Completed	`NCT02521948` - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device	N/A
Completed	`NCT03330002` - MANTA Registry for Vascular Large-bore Closure
Completed	`NCT02908880` - MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study	N/A
Completed	`NCT02406612` - X-Seal EU Post-Market Clinical Follow-Up Protocol	N/A